Literature DB >> 27091893

Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.

Tanja Dudenbostel1, Mohammed Siddiqui2, Suzanne Oparil2, David A Calhoun2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27091893      PMCID： PMC5425297          DOI： 10.1161/HYPERTENSIONAHA.116.06587

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  37 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Resistant hypertension. Introduction and definitions.

Authors:  R W Gifford
Journal:  Hypertension       Date:  1988-03       Impact factor: 10.190

3.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

4.  Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.

Authors:  George Thomas; Dawei Xie; Hsiang-Yu Chen; Amanda H Anderson; Lawrence J Appel; Shirisha Bodana; Carolyn S Brecklin; Paul Drawz; John M Flack; Edgar R Miller; Susan P Steigerwalt; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Mahboob Rahman
Journal:  Hypertension       Date:  2015-12-28       Impact factor: 10.190

5.  Resistant hypertension revisited: a comparison of two university-based cohorts.

Authors:  Jay P Garg; William J Elliott; Amy Folker; Munavvar Izhar; Henry R Black
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

6.  Resistant hypertension: comparing hemodynamic management to specialist care.

Authors:  Sandra J Taler; Stephen C Textor; Jo Ellen Augustine
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

7.  Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Am Soc Hypertens       Date:  2013-07-23

8.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321

10.  Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.

Authors:  Steven M Smith; Tianyao Huo; B Delia Johnson; Vera Bittner; Sheryl F Kelsey; Diane Vido Thompson; C Noel Bairey Merz; Carl J Pepine; Rhonda M Cooper-Dehoff
Journal:  J Am Heart Assoc       Date:  2014-02-28       Impact factor: 5.501
View more
  19 in total

Review 1.  Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Authors:  Patricia Van der Niepen; Patrick Rossignol; Jean-Philippe Lengelé; Elena Berra; Pantelis Sarafidis; Alexandre Persu
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

Review 2.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

3.  Performance of NoSAS score versus Berlin questionnaire for screening obstructive sleep apnoea in patients with resistant hypertension.

Authors:  Sara Q C Giampá; Rodrigo P Pedrosa; Carolina C Gonzaga; Adriana Bertolami; Celso Amodeo; Sofia F Furlan; Luiz A Bortolotto; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  J Hum Hypertens       Date:  2018-05-23       Impact factor: 3.012

4.  Prevalence of Apparent Treatment-Resistant Hypertension.

Authors:  Daniel W Jones; Donald Clark; Marion R Wofford
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 5.  The Potential Role of Obstructive Sleep Apnoea in Refractory Hypertension.

Authors:  Grace Oscullo; E Sapiña-Beltrán; Gerard Torres; Enrique Zaldivar; Ferran Barbé; Miguel Angel Martinez-Garcia
Journal:  Curr Hypertens Rep       Date:  2019-06-10       Impact factor: 5.369

Review 6.  Resistant Hypertension: Mechanisms and Treatment.

Authors:  Andrew Y Hwang; Eric Dietrich; Carl J Pepine; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

Review 7.  Should All Patients with Resistant Hypertension Receive Spironolactone?

Authors:  Ján Rosa; Tomáš Zelinka; Ondřej Petrák; Branislav Štrauch; Robert Holaj; Jiří Widimský
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

8.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 9.  Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?

Authors:  J C Yugar-Toledo; V Brunelli; J F Vilela-Martin; A Fattori; H Moreno
Journal:  Curr Hypertens Rep       Date:  2018-03-27       Impact factor: 5.369

10.  Factors associated with the changes from a resistant to a refractory phenotype in hypertensive patients: a Pragmatic Longitudinal Study.

Authors:  Cristina Navarro-Soriano; Miguel-Angel Martínez-García; Gerard Torres; Ferrán Barbé; Candela Caballero-Eraso; Patricia Lloberes; Trinidad Diaz Cambriles; María Somoza; Juan F Masa; Mónica González; Eva Mañas; Mónica de la Peña; Francisco García-Río; Josep María Montserrat; Alfonso Muriel; Grace Oscullo; Laura Feced Olmos; Alberto García-Ortega; David Calhoun; Francisco Campos-Rodriguez
Journal:  Hypertens Res       Date:  2019-06-17       Impact factor: 3.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.